Breaking News on Global Pharmaceutical Technology & Manufacturing

Has Hospira beaten Myriad in Javelin competition?

13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).

Dainippon expands RNAi delivery deal with Silence Therapeutics

31-Mar-2010 - Silence Therapeutics says extension of RNAi drug delivery collaboration by Dainippon Sumitomo is evidence of technology’s potential.

Schott posts fiscal 09 loss, but predicts double-digit growth

23-Mar-2010 - Industrial glass maker Schott ended a “rather difficult” fiscal 2009 with a loss but says rise in drug packaging sales will help drive double-digit earnings growth in current financial year.

News in brief

Astellas' go to courts in $3.5bn pursuit of OSI

03-Mar-2010 - Reports suggest that Japanese drugmaker Astellas Pharma has gone to the US courts to prevent takeover target OSI Pharmaceuticals from impeding its efforts just days after it tabled its $3.5bn...

News in brief

Aurelius buys fine chemicals supplier Isochem

01-Mar-2010 - German investment group Aurelius AG has acquired French fine chemicals supplier Isochem from state owned firm Groupe SNPE.

Merck KGaA to buy Millipore for €5bn

01-Mar-2010 - German pharmaceutical firm Merck KGaA says proposed Millipore acquisition will transform its chemicals unit and give it a more balanced business profile.

Breaking News

RecipharmCobra Biologics launches today

22-Feb-2010 - RecipharmCobra Biologics (RCB) launched today as a specialist biologics contract development and manufacturing organization (CDMO).

Merck & Co to reduce workforce 15%

17-Feb-2010 - Merck & Co says manufacturing and R&D jobs will go as part of the post acquisition workforce reduction programme it announced yesterday.

News in brief

Hospira takeover of Orchid’s injectables to complete in March

17-Feb-2010 - Hospira’s acquisition of Orchid Chemicals and Pharmaceuticals generic injectables business is on track to complete next month now the Hart-Scott-Rodino period required by the US Federal Trade Commission has elapsed....

Actavis to boost tablet capacity; and looking at Ratiopharm

08-Feb-2010 - Icelandic generics firm Actavis says expansion of its tablet plant will boost production capacity 50 per cent and create 50 new jobs.

Pfizer, Roche and GSK report 2009 results

04-Feb-2010 - In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand...

Amcor completes Alcan acquisition

02-Feb-2010 - Global packaging giant Amcor today announced that its acquisition of Alcan Packaging had been completed as it spelled out what the move would mean for suppliers and customers.

Keller buys Lehigh to boost pharma label capacity

02-Feb-2010 - Keller-Crescent has acquired Puerto Rico-based Lehigh Press to expand its capacity for producing pharmaceutical labels, inserts and outserts.

Watson buys Eden Biodesign

01-Feb-2010 - US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.

Recipharm adds large-scale lyophilisation to offering

27-Jan-2010 - Recipharm says acquisition of German CMO Wasserburger Arzneimittelwerk from Hospira adds large-scale lyophilisation services to its offering.

Castle Harlan buys Pretium and Novapak

20-Jan-2010 - Blow-moulded packaging companies Pretium Packaging and Novapak Corporation have been taken over by New-York-based buyout firm Castle Harlan Inc in a deal worth $200m.

Ranbaxy buys Biovel to strengthen in biologics and vaccines

20-Jan-2010 - Ranbaxy Laboratories has strengthened its vaccine and biologics manufacturing capabilities by acquiring India-based Biovel Lifesciences.

Pall buys MRT for mini MTPD technology

13-Jan-2010 - Pall says its acquisition of MicroReactor Technologies (MRT) broadens its offering in the $1bn (€689m) a year global biopharmaceutical process development market.

News in brief

API production starts at Evonik's new plant

11-Jan-2010 - Production has begun at the US API plant German chemicals firm Evonik Industries recently bought from drugmaker Eli Lilly.

Luitpold buys PharmaForce for generic injectables

07-Jan-2010 - Daiichi-Sankyo subsidiary Luitpold Pharmaceuticals has acquired PharmaForce, giving it a 40,000 sq ft cGMP compliant sterile manufacturing facility and a 20,000 sq ft API production plant.

Ranbaxy sells China JV and changes strategy

05-Jan-2010 - Ranbaxy Laboratories has sold its Chinese JV, Ranbaxy Guangzhou China Limited (RGCL), as part of a new approach to the country’s rapidly expanding drug market.

Amcor gets US approval for Alcan takeover

05-Jan-2010 - The US Department of Justice (DOJ) has given partial approval for Amcor’s takeover of Alcan after announcing it would now limit its review to Alcan’s Medical Flexible operations.

DMV-Fonterra builds pharma lactose biz with Domo deal

05-Jan-2010 - Ownership of FrieslandCampina Domo’s pharmaceutical lactose business will be transferred to DMV-Fonterra Excipients, the 50/50 JV set up by Domo owner Royal FrieslandCampina and partner Fonterra.

Novartis to acquire Alcon

04-Jan-2010 - Novartis intends to acquire the remaining 75 per cent of Alcon for $39.3bn (€27.3bn), adding to the shares it bought in April 2008 and giving the big pharma control of...

Merck & Co to buy Avecia Biologics

21-Dec-2009 - US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector with the acquisition of Tees Valley-based Avecia Biologics.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...